Physician profile
Thomas Michael Johnson
NPI 1063489623
$1,358.33
in general payments reported to CMS, 2019-2025
12 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.45 · 2022: $318 · 2023: $421 · 2024: $328 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $855 · Education: $98.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.48 |
| Education | $98.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $268.97 | 2023-2024 | Arexvy, Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.79 | 2022-2024 | |
| Harmony Biosciences LLC | $183.76 | 2021-2023 | Wakix |
| Resmed Corp | $150.74 | 2023-2025 | |
| Verona Pharma, INC. | $129.92 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $120.74 | 2021-2022 | |
| Inspire Medical Systems, INC. | $107.18 | 2023 | Inspire |
| Pulmonx Corporation | $63.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.93 | 2021-2023 | Airsupra, Breztri |
| Regeneron Healthcare Solutions, INC. | $28.62 | 2024 | Dupixent |
| Axsome Therapeutics, INC. | $20.47 | 2022 | |
| Insmed, INC. | $14.14 | 2025 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.